Formation of a transplacental mutagen, 1,3-Di(4-sulfamoylphenyl)triazene, from sodium nitrite and sulfanilamide in human gastric juice and in the stomachs of hamsters.
1,3-Di(4-sulfamoylphenyl)triazene was abundantly produced by incubation of sulfanilamide (SA) and NaNO2 in human gastric juice. This reaction also occurred in acetate buffer (pH approximately 4) at 37 degrees C as well as in hydrochloric acid (pH < 1) under ice cooling, with the product forming in almost the same amount. This phenomenon indicated the broad range of conditions under which the reaction occurs. The intragastric formation of this triazene was also demonstrated in Syrian golden hamsters by the concurrent administration of SA and NaNO2. Mutants resistant to 8-azaguanine were induced in a dose-dependent manner in the culture of embryo cells that were derived from pregnant hamsters 24 hours after ip injection of this triazene.
D000818:Animals; D006224:Cricetinae; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D008431:Maternal-Fetal Exchange; D008647:Mesocricetus; D009153:Mutagens; D009573:Nitrites / Q000378:metabolism*; D011247:Pregnancy; D012977:Sodium Nitrite / Q000378:metabolism*; D013424:Sulfanilamides / Q000378:metabolism*; D014226:Triazenes / Q000096:biosynthesis* / Q000633:toxicity; D000096926:Benzenesulfonamides
D009153:Mutagens; D009573:Nitrites; D012977:Sodium Nitrite; D013424:Sulfanilamides; D014226:Triazenes; C026587:1,3-di(4-sulfamoylphenyl)triazene; D000096926:Benzenesulfonamides